0000820081-14-000030.txt : 20140904 0000820081-14-000030.hdr.sgml : 20140904 20140904160729 ACCESSION NUMBER: 0000820081-14-000030 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140902 FILED AS OF DATE: 20140904 DATE AS OF CHANGE: 20140904 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CAMBREX CORP CENTRAL INDEX KEY: 0000820081 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222476135 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE MEADOWLANDS PLZ CITY: E RUTHERFORD STATE: NJ ZIP: 07073 BUSINESS PHONE: 2018043000 MAIL ADDRESS: STREET 1: ONE MEADOWLANDS PLAZA CITY: E. RUTHERFORD STATE: NJ ZIP: 07073 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KLOSK STEVEN M CENTRAL INDEX KEY: 0001192621 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10638 FILM NUMBER: 141083311 MAIL ADDRESS: STREET 1: C/O CAMBREX CORP STREET 2: ONE MEADOWLANDS PLZ CITY: EAST RUTHERFORD STATE: NJ ZIP: 07073 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2014-09-02 0000820081 CAMBREX CORP CBM 0001192621 KLOSK STEVEN M ONE MEADOWLANDS PLAZA EAST RUTHERFORD NJ 07073 0 1 0 0 President & CEO Common Stock 2014-09-02 4 M 0 60000 5.605 A 205870 D Common Stock 2014-09-02 4 S 0 60000 22.0125 D 145870 D Common Stock 2014-09-03 4 M 0 66257 5.605 A 212127 D Common Stock 2014-09-03 4 S 0 66257 22.0156 D 145870 D Stock Option (Right to Buy) 5.605 2014-09-02 4 M 0 60000 0 D 2015-05-14 Common Stock 60000 66257 D Stock Option (Right to Buy) 5.605 2014-09-03 4 M 0 66257 0 D 2015-05-14 Common Stock 66257 0 D The option, representing a right to purchase a total of 150,000 shares, became exercisable in four equal annual installments beginning on May 14, 2009, which was the first anniversary of the date on which the option was granted. The price reported in Column 4 in Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.0 to $22.19 inclusive. The reporting person undertakes to provide to Cambrex Corporation, any security holder of Cambrex Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote (2) to this Form 4. The price reported in Column 4 in Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.0 to $22.135 inclusive. The reporting person undertakes to provide to Cambrex Corporation, any security holder of Cambrex Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote (3) to this Form 4. Linda Kresse for Steven M. Klosk by POA 2014-09-04